Suchergebnisse - "Cantini, Fabrizio"

PubPharm (27)

1

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

enthalten in: Expert review of anti-infective therapy | 2018

von Goletti, D. | Petrone, L. | Ippolito, G. | +3

2

A national survey on the management of psoriatic arthritis using the Delphi method

enthalten in: Clinical and experimental rheumatology | 2017

von Lubrano, E. | Cantini, F. | Mathieu, A. | +4

3

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics

enthalten in: Mediators of inflammation | 2017

von Cantini, F. | Nannini, C. | Niccoli, L. | +3

4

Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Bonovas, S. | Minozzi, S. | Lytras, T. | +13

5

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2016

von Minozzi, S. | Bonovas, S. | Lytras, T. | +14

6

Influence of anti-TNF immunogenicity on safety in rheumatic disease : a narrative review

enthalten in: Expert opinion on drug safety | 2016

von Matucci, A. | Cammelli, D. | Cantini, F. | +7

7

Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease : a focus on rheumatoid arthritis

enthalten in: Expert opinion on drug safety | 2016

von Tocci, G. | Goletti, D. | Marino, V. | +4

8

enthalten in: Expert opinion on drug safety | 2016

von Cantini, F.

9

Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy : an Italian nationwide survey

enthalten in: International journal of rheumatic diseases | 2016

von Cantini, F. | Lubrano, E. | Marchesoni, A. | +5

10

Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors : the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study

enthalten in: Clinical and experimental rheumatology | 2016

von Olivieri, I. | Cortesi, P. | de Portu, S. | +13